| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8961 |
| Human Intestinal Absorption | HIA+ | 0.9724 |
| Caco-2 Permeability | Caco2- | 0.6590 |
| P-glycoprotein Substrate | Non-substrate | 0.8283 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9918 |
| Non-inhibitor | 0.9869 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9494 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5936 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7859 |
| CYP450 2D6 Substrate | Non-substrate | 0.9211 |
| CYP450 3A4 Substrate | Non-substrate | 0.8163 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9582 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9388 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9775 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9859 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9585 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9840 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9728 |
| Non-inhibitor | 0.9824 |
| AMES Toxicity | Non AMES toxic | 0.9765 |
| Carcinogens | Carcinogens | 0.5797 |
| Fish Toxicity | Low FHMT | 0.6036 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9831 |
| Honey Bee Toxicity | High HBT | 0.6466 |
| Biodegradation | Ready biodegradable | 0.9469 |
| Acute Oral Toxicity | III | 0.7246 |
| Carcinogenicity (Three-class) | Non-required | 0.7580 |